| Revenue growth | 19% YoY FY26 |
|---|---|
| Margins | EBITDA margin flat at 12%; Gross margins compressed to 56% |
| Demand visibility | Strong acceptance of Sanket Jumbo cotton; Paddy/Cotton portfolio share 58% |
| Management confidence | High; expanding into international markets like Uzbekistan |
Growth
FY26 Revenue grew 19% YoY to ₹4,316 Mn; PBT rose 11%. Cotton volume up 22.35%, Paddy up 25%.
Outlook
Entering international markets with first-ever ₹15 Cr milestone in Uzbekistan. Targeting core crop portfolio expansion (Cotton/Paddy).
Risks
PNS segment declined 19% due to China export restrictions. Vegetable seed volumes dropped 15%.
Earnings Call filed with BSE, NSE: NATHBIOGEN. Summary written with AI assistance from the document.
Nath Bio-Genes (India) Ltd: key numbers
- Share price
- ₹140.13
- Market cap
- ₹266.3 Cr
- Revenue (annual)
- ₹445.1 Cr
- Net profit (annual)
- ₹41.63 Cr
- P/E (TTM)
- 7.3×Sector 28.6×
- Promoter holding
- 45.60%+0.00% QoQ
- FII holding
- 0.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nath Bio-Genes (India) Ltd
All →Nath Bio-Genes (India) Annual General Meeting
Nath Bio-Genes (India) Ltd held its 33rd AGM on September 24, 2026. Shareholders approved all five resolutions, including a final dividend of ₹2/- per share.
Nath Bio-Genes (India) Annual General Meeting
Nath Bio-Genes (India) Ltd issued notice for its 33rd Annual General Meeting, to be held on September 24, 2026, alongside the Annual Report for FY2025-26.
Nath Bio-Genes (India) ED Probe / Tax Survey
SEBI has initiated a forensic audit of Nath Bio-Genes (India) Ltd for financial years 2020-21 to 2025-26. CNK & Associates LLP has been appointed as the forensic auditor.
- Execution
- FY 2020-21 to 2025-26
Nath Bio-Genes (India) Investor Presentation: Key Takeaways
Nath Bio-Genes reported strong Q1 FY27 results with Revenue and EBITDA growing 15% and 17% YoY respectively. The company continues to focus on high-yield cotton, maize, and paddy seeds.
Nath Bio-Genes (India) Q1 FY27 Results: Net Profit ₹32.3 Cr, Up 14.1% YoY
Nath Bio-Genes (India) Ltd reported revenue from operations of ₹328.4 Cr (+15.8% YoY) and net profit of ₹32.3 Cr (+14.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹32.3 Cr · +14.1% YoY
Nath Bio-Genes (India) Other Announcement
Nath Bio-Genes (India) Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This disclosure provides the updated distribution of shareholding across various investor categories.